- Home
- CSPI vs NVCT Comparison
CSPI vs NVCT Comparison
Compare CSPI & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CSPI | NVCT |
|---|---|---|
| Founded | 1968 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.8M | 197.0M |
| IPO Year | 1987 | 2022 |
Fundamental Metrics
Financial Performance| Metric | CSPI | NVCT |
|---|---|---|
| Price | $13.22 | $7.93 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $15.33 |
| AVG Volume (30 Days) | 22.5K | ★ 102.5K |
| Earning Date | 12-16-2025 | 11-04-2025 |
| Dividend Yield | ★ 0.89% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $58,730,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.36 | N/A |
| 52 Week Low | $9.65 | $4.44 |
| 52 Week High | $21.95 | $11.52 |
Technical Indicators
Market Signals| Indicator | CSPI | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 54.92 | 71.56 |
| Support Level | $12.55 | $6.47 |
| Resistance Level | $15.00 | $7.77 |
| Average True Range (ATR) | 0.91 | 0.40 |
| MACD | -0.02 | 0.12 |
| Stochastic Oscillator | 58.55 | 92.07 |
Price Performance
Historical ComparisonAbout CSPI CSP Inc.
CSP Inc develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments, namely Technology Solutions, where the company focuses on value-added reseller integrated solutions, including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company designs, manufactures, and delivers products and services to customers that require specialized cybersecurity services, networking, and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates the majority of its revenue from the Americas.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.